UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 103 filers reported holding UROGEN PHARMA LTD in Q3 2023. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $466 | +35.5% | 33,250 | 0.0% | 0.16% | +45.9% |
| Q2 2023 | $344 | +12.1% | 33,250 | 0.0% | 0.11% | +1.8% |
| Q1 2023 | $307 | -99.9% | 33,250 | 0.0% | 0.11% | -1.8% |
| Q3 2022 | $277,000 | +1.8% | 33,250 | 0.0% | 0.11% | +5.7% |
| Q2 2022 | $272,000 | -6.2% | 33,250 | 0.0% | 0.10% | +28.0% |
| Q1 2022 | $290,000 | -8.5% | 33,250 | -0.3% | 0.08% | +1.2% |
| Q4 2021 | $317,000 | -43.5% | 33,350 | 0.0% | 0.08% | -48.7% |
| Q3 2021 | $561,000 | -31.2% | 33,350 | -37.5% | 0.16% | -31.3% |
| Q2 2021 | $815,000 | +18.3% | 53,350 | +50.9% | 0.23% | -1.3% |
| Q1 2021 | $689,000 | -4.3% | 35,350 | -11.5% | 0.23% | -10.0% |
| Q4 2020 | $720,000 | -16.2% | 39,950 | -10.3% | 0.26% | -21.5% |
| Q3 2020 | $859,000 | -35.8% | 44,550 | -12.9% | 0.33% | -45.8% |
| Q2 2020 | $1,337,000 | +42.7% | 51,175 | -2.6% | 0.61% | -3.2% |
| Q1 2020 | $937,000 | -58.1% | 52,550 | -21.6% | 0.63% | -15.1% |
| Q4 2019 | $2,237,000 | +41.6% | 67,025 | +1.1% | 0.74% | +18.6% |
| Q3 2019 | $1,580,000 | -31.8% | 66,300 | +2.8% | 0.62% | -31.1% |
| Q2 2019 | $2,318,000 | -21.8% | 64,500 | -19.7% | 0.91% | -27.0% |
| Q1 2019 | $2,966,000 | -7.5% | 80,300 | +7.9% | 1.24% | -25.9% |
| Q4 2018 | $3,206,000 | -13.4% | 74,450 | -5.1% | 1.68% | +16.1% |
| Q3 2018 | $3,704,000 | +54.7% | 78,425 | +63.0% | 1.44% | +44.0% |
| Q2 2018 | $2,395,000 | +5.7% | 48,125 | +5.6% | 1.00% | -2.8% |
| Q1 2018 | $2,265,000 | +189.6% | 45,575 | +116.8% | 1.03% | +181.7% |
| Q4 2017 | $782,000 | +17.6% | 21,025 | -0.4% | 0.37% | +26.6% |
| Q3 2017 | $665,000 | – | 21,100 | – | 0.29% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 2,620,545 | $36,713,835 | 6.69% |
| Wildcat Capital Management, LLC | 495,606 | $6,943,440 | 2.79% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 508,883 | $7,129,451 | 2.16% |
| Opaleye Management Inc. | 320,000 | $4,483,200 | 1.46% |
| AlphaCentric Advisors LLC | 165,000 | $2,311,650 | 1.31% |
| Soleus Capital Management, L.P. | 372,000 | $5,211,720 | 0.48% |
| EAM Investors, LLC | 170,523 | $2,389,027 | 0.46% |
| RA Capital Management | 1,483,697 | $20,786,595 | 0.41% |
| Parkman Healthcare Partners LLC | 145,311 | $2,035,807 | 0.37% |
| MENORA MIVTACHIM HOLDINGS LTD. | 2,303,031 | $32,265,464 | 0.29% |